Biolife Solutions (BLFS) Net Cash Flow (2010 - 2026)

Biolife Solutions (BLFS) has reported Net Cash Flow for 17 consecutive years, with -$10.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Cash Flow rose 64.08% year-over-year to -$10.2 million; the TTM figure through Mar 2026 stood at -$44.1 million (down 218.75% YoY), while the FY2025 annual figure was -$62.3 million, down 204.0% from the prior year.
• Net Cash Flow fell to -$10.2 million in Q1 2026 per BLFS's latest filing, from $3.6 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $71.2 million in Q4 2024 and bottomed at -$35.3 million in Q2 2022.
• Historically, Net Cash Flow has averaged -$2.8 million across 5 years, with a median of -$2.4 million in 2025.
• Annual changes were most pronounced in 2022 — Net Cash Flow soared 407.94% — and 2024, when it sank 1522.99%.
• Biolife Solutions' Net Cash Flow stood at -$7.7 million in 2022, then jumped by 310.25% to $16.1 million in 2023, then jumped by 341.96% to $71.2 million in 2024, then plunged by 95.0% to $3.6 million in 2025, then tumbled by 387.21% to -$10.2 million in 2026.
• Business Quant data shows BLFS's Net Cash Flow at -$10.2 million in Q1 2026, $3.6 million in Q4 2025, and -$2.4 million in Q3 2025.